Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacotherapy in severe liver failure]

K Hruby, G Kleinberger

    Leber, Magen, Darm
    |October 1, 1982
    PubMed
    Summary

    Drug pharmacokinetics and pharmacodynamics significantly change in severe liver failure due to hepatic or extrahepatic factors. Careful drug dosing and risk classification are crucial for managing patients with liver dysfunction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Antidotes in clinical toxicology].

    Medizinische Klinik, Intensivmedizin und Notfallmedizin·2013
    Same author

    Inadvertent duplicate publication: Severe poisoning with slow release theophylline.

    British medical journal (Clinical research ed.)·2010
    Same author

    Ophthalmological experience with penicillin.

    Wiener klinische Wochenschrift·2010
    Same author

    Recent examination results on the clinic and pathology of the vitreous.

    Wiener klinische Wochenschrift·2010
    Same author

    Influence of a novel amino acid solution (enriched with the dipeptide glycyl-tyrosine) on plasma amino acid concentration of patients with acute renal failure.

    Clinical nutrition (Edinburgh, Scotland)·2006
    Same author

    [Comparison of the cost of treatment of premature labor with atosiban or beta-sympathomimetics from the perspective of the health care payer--a pharmacoeconomic model].

    Ceska gynekologie·2004

    Area of Science:

    • Pharmacology
    • Hepatology
    • Drug Metabolism

    Context:

    • Severe liver failure alters drug pharmacokinetics and pharmacodynamics compared to healthy individuals.
    • These alterations stem from both hepatic (liver-related) and extrahepatic (outside the liver) mechanisms.
    • Understanding these changes is vital for effective patient management.

    Purpose:

    • To classify drugs based on their pharmacokinetic and pharmacodynamic alterations in liver failure.
    • To guide the adjustment of drug dosages in patients with severe liver dysfunction.
    • To highlight the importance of considering drug profiles for safe and effective treatment.

    Summary:

    • Drug clearance in the liver is influenced by blood flow (flow-limited) or metabolic capacity (capacity-limited).
    • Extrahepatic factors like protein binding and altered distribution volumes also impact drug behavior.
    • Dosage adjustments should prioritize pharmacokinetic profiles over solely relying on clinical effects.

    Impact:

    • Provides a framework for classifying drugs based on therapeutic risk in liver failure.
    • Suggests that drug level monitoring and risk stratification can optimize treatment plans.
    • Aims to improve patient outcomes and resource utilization in managing liver disease patients.

    Related Experiment Videos